DCF — BAPTIST HEALTH MEDICAL CENTER - LR
Enterprise Value: $-615.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-615.6M
Enterprise Value
$-204.4M
PV of Cash Flows
$-411.2M
PV of Terminal Value
$-662.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $672.4M | $-33.1M | -5.0% | $-61.5M | $-55.9M |
| Year 2 | $692.6M | $-27.1M | -4.0% | $-56.5M | $-46.7M |
| Year 3 | $713.4M | $-20.8M | -3.0% | $-51.0M | $-38.3M |
| Year 4 | $734.8M | $-17.8M | -2.0% | $-48.9M | $-33.4M |
| Year 5 | $756.8M | $-16.4M | -2.0% | $-48.5M | $-30.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-615.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$652.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.054188892414109194
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5